Why Chemotherapy-Induced Neuropathy is a Growing Challenge for the Peripheral Neuropathy Market
As cancer survival rates improve, the "Long-Term Side Effects" of treatment are coming into sharper focus. In 2026, the Peripheral Neuropathy Market is seeing a steady increase in cases of "Chemotherapy-Induced Peripheral Neuropathy" (CIPN). Many life-saving cancer drugs are unfortunately "Neurotoxic," meaning they can damage the nerves in the hands and feet as they fight the tumor. In 2026,...
0 Σχόλια 0 Μοιράστηκε 385 Views 0 Προεπισκόπηση
Προωθημένο